Tag: CBT > FDA Congress: Page 4

Connecticut

CTPharma Launches FDA-Approved Medical Cannabis Clinical Studies With Human Subjects

Research on alleviating stress and pain in patients to be done in partnership with the Yale School of Medicine.

November 11, 2019

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019